Opinion
The making of the Pfizer-BioNTech COVID-19 vaccine
We continue to identify improvements to increase production and are on track to deliver approximately 2.5 billion doses in 2021.
Mikael Dolsten, MD, PhD
We continue to identify improvements to increase production and are on track to deliver approximately 2.5 billion doses in 2021.